Verve Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
201 Brookline Avenue, Suite 601, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/8/2024, 07:32 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Jun 27, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report SC 13G/A Jan 29, 2024
SC 13G Report Jan 29, 2024
SC 13G/A Report Jan 23, 2024
SC 13G/A Report SC 13G/A Dec 11, 2023
SC 13G/A Report Dec 11, 2023
SC 13G/A Report 2023 FORM SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G/A(#1E) Feb 13, 2023
SC 13G/A Report SC 13G/A Feb 10, 2023
SC 13G Report Feb 10, 2023
SC 13G Report SC 13G Feb 10, 2023
SC 13G/A Report Feb 9, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G Report Feb 7, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
SC 13G/A Report Aug 10, 2022
SC 13G Report SC 13G Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G Feb 9, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G Report Jan 24, 2022
SC 13G/A Report 13G/A Dec 28, 2021
SC 13G Report SEC SCHEDULE 13G Jun 28, 2021
SC 13G Report Jun 23, 2021
SC 13G Report Jun 23, 2021